The UvA-LINKER will give you a range of other options to find the full text of a publication (including a direct link to the full-text if it is located on another database on the internet).
De UvA-LINKER biedt mogelijkheden om een publicatie elders te vinden (inclusief een directe link naar de publicatie online als deze beschikbaar is in een database op het internet).

Zoekresultaten

Zoekopdracht: faculteit: "ACTA" en publicatiejaar: "2009"

AuteursM. Knippenberg, M.N. Helder, B.Z. Doulabi, R.A. Bank, P.I.J.M. Wuisman, J. Klein-Nulend
TitelDifferential effects of bone morphogenetic protein-2 and transforming growth factor-beta 1 on gene expression of collagen-modifying enzymes in human adipose tissue-derived mesenchymal stem cells
TijdschriftTissue engineering, Pt. A
Jaargang15
Jaar2009
Nummer8
Pagina's2213-2225
ISSN19373341
FaculteitACTA
SamenvattingAdipose tissue–derived mesenchymal stem cells (AT-MSCs) in combination with bone morphogenetic protein-2 (BMP-2) or transforming growth factor-β1 (TGF-β1) are under evaluation for bone tissue engineering. Posttranslational modification of type I collagen is essential for functional bone tissue with adequate physical and mechanical properties. We investigated whether BMP-2 (10–100ng/mL) and/or TGF-β1 (1–10ng/mL) affect gene expression of α2(I) procollagen and collagen-modifying enzymes, that is, lysyl oxidase and lysyl hydroxylases 1, 2, and 3 (encoded by PLOD1, 2, and 3), by human AT-MSCs. BMP-2, but not TGF-β1, increased alkaline phosphatase activity after 28 days, indicating osteogenic differentiation of AT-MSCs. At day 4, both BMP-2 and TGF-β1 upregulated α2(I) procollagen and PLOD1, which was downregulated at day 28. TGF-β1, but not BMP-2, downregulated PLOD3 at day 28. Lysyl oxidase was upregulated by TGF-β1 at day 4 and by BMP-2 at day 7. Neither BMP-2 nor TGF-β1 affected PLOD2. In conclusion, these results suggest that AT-MSCs differentially respond to BMP-2 and TGF-β1 with changes in gene expression of collagen-modifying enzymes. AT-MSCs may thus be able to appropriately modify type I collagen to form a functional bone extracellular matrix for tissue engineering, dependent on the growth factor added.
Soort documentArtikel
Document finderUvA-Linker